NCT02721173View on ClinicalTrials.gov

Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

December 31, 2016

Study Completion Date

January 31, 2017

Conditions
Acne Vulgaris
Interventions
DRUG

Tazarotene 0.1% gel plus clindamycin 1% gel

Medications will be advised to apply once daily in the evening after facial cleansing. Clindamycin will be applied first and tazarotene will be applied 5-10 minutes later.

DRUG

Adapalene 0.1% gel plus clindamycin 1% gel

Medications will be advised to apply once daily in the evening after facial cleansing. Clindamycin will be applied first and adapalene will be applied 5-10 minutes later.

Trial Locations (1)

751019

AIIMS, Bhubaneswar, Bhubaneswar

All Listed Sponsors
lead

All India Institute of Medical Sciences, Bhubaneswar

OTHER

NCT02721173 - Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris | Biotech Hunter | Biotech Hunter